| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.2.i
Julier A et al. (2012)
|
Xla Wt + pou5f3.2
NF11-11.5 (in situ hybridization)
|
|
|
|
|
fig.2.n
Julier A et al. (2012)
|
Xla Wt + pou5f3.2
NF11-11.5 (in situ hybridization)
|
|
|
|
fig.5.b
Lai F et al. (2012)
|
Xla Wt + nanos1 MO
NF11 (immunohistochemistry)
|
|
|
|
fig.3.b
Mir A et al. (2007)
|
Xla Wt + foxi1
NF11 (RT-PCR)
|
|
|
|
fig.1.o
Cao Y et al. (2006)
|
Xla Wt + Mmu.Pou5f1
NF11.5 (in situ hybridization)
|
|
|
|
|
fig.1.p
Cao Y et al. (2006)
|
Xla Wt + Mmu.Pou5f1
NF11.5 (RT-PCR)
|
|
|
|
|
fig.1.n
Cao Y et al. (2006)
|
Xla Wt + pou5f3.1
NF11.5 (in situ hybridization)
|
|
|
|
|
fig.1.l
Cao Y et al. (2006)
|
Xla Wt + pou5f3.2
NF11.5 (in situ hybridization)
|
|
|
|
|
fig.1.p
Cao Y et al. (2006)
|
Xla Wt + pou5f3.2
NF11.5 (RT-PCR)
|
|
|
|
fig.5.j
Cao Y et al. (2006)
|
Xla Wt + pou5f3.2 MO + pou5f3.3 MO
NF12.5 (in situ hybridization)
|
|
|